Non-DHA infant formulas "cannot support" DHA levels of breast-fed infants -- Wyeth study.
This article was originally published in The Tan Sheet
Executive Summary
NON-DHA FORMULAS "CANNOT SUPPORT" DHA LEVELS OF BREAST-FED INFANTS, a multi-center safety and efficacy study in 288 premature infants conducted by Wyeth-Ayerst concludes. "These data provide further confirmation that term formulas that are not supplemented with preformed DHA cannot support tissue DHA levels similar to those seen in breast-fed infants," Wyeth Nutritionals International Clinical Nutrition Department Senior Director Arthur Euler, MD, et al., state, reporting on the one-year follow-up data from the trial.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning